 |
 | Home |  |  |  |  |
| ||||||||
| | | ||||||
| | |
 |  |  |  |  |  |  |  |
| Site Group Page (References Reporting High Throughput Detection Method) |
 |
 |
Site Information |  |
||||||||||||||||||
|
||||||||||||||||||||
|
References | |
|
(2010) CST Curation Set: 9753; Year: 2010; Biosample: HCT 116; Disease: colorectal carcinoma; Treatment: control; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-r(methylation) Antibody Used to Purify Peptides prior to MS2: Mono-Methyl Arginine (Me-R(4)-100) Rabbit mAb Cat#: 8015
Curated Info |
|
|
(2010) CST Curation Set: 9115; Year: 2010; Biosample: PY2; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2010) CST Curation Set: 9113; Year: 2010; Biosample: NTERA-2; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2010) CST Curation Set: 9112; Year: 2010; Biosample: NCCIT; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2010) CST Curation Set: 8862; Year: 2010; Biosample: HCT 116; Disease: colorectal carcinoma; Treatment: normal; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2010) CST Curation Set: 8863; Year: 2010; Biosample: HCT 116; Disease: colorectal carcinoma; Treatment: normal; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2010) CST Curation Set: 8860; Year: 2010; Biosample: HCT 116; Disease: colorectal carcinoma; Treatment: normal; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2009) CST Curation Set: 6812; Year: 2009; Biosample: PC-12; Disease: pheochromocytoma; Treatment: NGF; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2009) CST Curation Set: 6811; Year: 2009; Biosample: PC-12; Disease: pheochromocytoma; Treatment: NGF; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2009) CST Curation Set: 6009; Year: 2012; Biosample: MEF; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2009) CST Curation Set: 6008; Year: 2012; Biosample: MEF; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2008) CST Curation Set: 5149; Year: 2008; Biosample: HCT116; Disease: colorectal carcinoma; Treatment: Adox; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2008) CST Curation Set: 3812; Year: 2008; Biosample: brain, embryonic; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2008) CST Curation Set: 3813; Year: 2008; Biosample: heart; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
|
(2008) CST Curation Set: 3814; Year: 2008; Biosample: liver; Disease: -; Treatment: untreated; Specificity of Antibody Used to Purify Peptides prior to MS2: anti-Rme1
Curated Info |
|
